ReviewFrontiers in immunology2026
Gut microbiota dysbiosis and joint diseases: advances in the gut-joint axis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the proposal of the "gut-joint axis" concept has provided a new perspective for understanding joint diseases. Research indicates that gut dysbiosis can drive the onset and progression of various joint diseases, including osteoarthritis, rheumatoid arthritis, spondyloarthritis, and gouty arthritis, through multiple pathways such as mediating systemic immune inflammation, disrupting metabolic homeostasis, and increasing intestinal permeability. This article systematically reviews the impact of specific alterations in the gut microbiota on different joint diseases and their underlying mechanisms, summarizes these shared and disease-specific mechanisms, and discusses novel diagnostic and therapeutic strategies targeting the microbiota, aiming to open new avenues for the prevention and treatment of joint diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.